Piper Sandler analyst David Westenberg lowered the firm’s price target on Neogen (NEOG) to $13 from $16.50 and keeps a Neutral rating on the shares following the company’s earnings report. The firm notes that its change in price target primarily reflects its updated estimates and updated multiple.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG: